Codex

Hold: probability-weighted value is ₹234 versus ₹226 (+3.4%), reward/risk asymmetry is 1.19x, and position size should stay capped at 1.0% until underwriting and demerger execution both confirm.

What's Next

The next 3-6 months have event flow, but only one true rerating lever: repeatable earnings quality from Care-led underwriting and clean execution milestones on demerger.

Loading...
No Results

What the market is likely to watch most closely is simple: does Care stop dragging consolidated profitability, and do demerger milestones move on schedule without governance noise.

The Verdict

The setup is not a clean long today. Deleveraging and control clarity are real positives, but the edge is thin because valuation already discounts part of that repair while earnings conversion remains unstable.

Current Price (₹)

226

Probability-Weighted Value (₹)

233.8

3.4% Expected Return

Asymmetry (Reward/Risk)

1.19

Suggested Max Position (% NAV)

1.0

Conviction (10-point)

4.8
Loading...
Loading...
No Results
Loading...
No Results
Loading...

What the market may still be missing is that CAP removal plus promoter-backed recap can create a cleaner earnings path than current skepticism implies. The counterpoint is stronger today: that improvement is not yet visible in stable consolidated ROE, so mispricing is modest.

At current odds and path risk, this is a watchlist-to-small-position setup, not a high-conviction add.